This is the second pathway on equity capital markets. In this pathway we will discuss the different products available in the equity capital markets in more depth.
Watch all the videos and pass the test to obtain a certificate showing your completion of this Pathway. Certificates can be shared directly to your LinkedIn profile and social media accounts.
8 videos • 1 hour 1 minute
James provides an introduction to convertible bonds - how they are structured, the advantages and disadvantages of their use.
James Eves • 16:13
James dives deeper into the technical aspects of convertible bonds.
James Eves • 20:40
James discusses exchangeable bonds by taking a look at the Spanish construction company, ACS. He discusses the size, terms and result of this issuance.
James Eves • 02:27
James delves into mandatory convertibles and their unique structure compared to standard convertibles. He dives into Bayer’s issuance in 2016 in part of its financing of acquiring Monsanto.
James Eves • 03:16
James speaks on synthetic convertibles and their most common form. He briefly touches on Glencore’s 2018 issuance of $500 million in synthetic convertibles.
James Eves • 02:50
In this discussion of warrants, James touches on the details of warrants and explains Siemens’ 2012 issuance.
James Eves • 03:00
As an alternative to issuing shares on offshore exchanges, companies can undertake equity issuance in international markets in the form of a depositary receipt (DR). Keith explains the benefits of DRs, what they are, and how they work.
Keith Mullin • 07:06
Investors buy shares in a company for two principal reasons: generating investment returns as shares rise in price, and receiving dividends. Keith briefly explains what dividends are, what considerations companies have when it comes to issuing dividends and how dividends impact share price.
Keith Mullin • 06:19